UP Pharmaceutical and Medical Device Policy 2023: Incentives for Life Sciences Manufacturing

Uttar Pradesh had a dedicated pharmaceutical policy going back to 2018, aimed at building up the state’s presence in drug manufacturing. The 2023 update — the UP Pharmaceutical and Medical Device Policy — widens that scope to explicitly bring in medical devices, a sector that’s grown fast in India and that the state clearly wants a share of. If your business sits anywhere in drug manufacturing, formulation, APIs, or medical device production, this is the policy governing your state-level incentives.

Why medical devices got added

Pharma and medical devices are regulated differently and have different manufacturing profiles, but they share enough — clean manufacturing requirements, quality certification needs, export orientation — that bundling them into one policy made sense from the state’s point of view. If you manufacture devices ranging from basic disposables to more complex diagnostic or therapeutic equipment, you’d now typically be evaluated under this combined policy rather than being left out of a pharma-only framework.

The kind of support available

As with other sectoral policies in UP, incentives here generally span capital subsidy for setting up or expanding manufacturing facilities, interest subsidy on term loans, stamp duty relief on land, and support for quality certification costs — which matters a lot in this sector given how central certifications like GMP or ISO standards are to being able to sell your product at all, domestically or for export. Some policies in this space also offer incentives specifically for R&D or testing infrastructure, recognizing that pharma and medical device businesses often need lab and testing capability beyond a standard factory shed. We’re not listing specific rates here since they vary by investment size and are subject to revision — best to have these confirmed for your specific project.

Clusters and parks

Pharma and medical device policies in various states, including UP, often tie into dedicated industrial parks or clusters set up for the sector, which can come with shared infrastructure benefits — effluent treatment, common testing facilities, and so on — beyond the direct financial incentives. If you’re setting up in one of these designated areas, it’s worth checking what shared infrastructure is available, since it can meaningfully affect your setup costs.

Compliance still comes first

Regulatory approvals from bodies like the state drug controller or CDSCO for devices remain the backbone of getting your business operational — the policy incentives are additive, not a substitute. Getting your Udyam, GST, and sector-specific licensing sequenced correctly matters as much here as the subsidy application itself.

If you’re setting up or expanding a pharma or medical device unit in UP, message us on WhatsApp — we can help you understand what incentives and compliance steps apply to your specific project.